Displaying 191 - 200 of 243
Alternative Name: Retinoic acid receptor (RAR) antagonists
Target
Active Status: Yes
User: Male
Mode: No
Developer: NICHD, Columbia University, University of Washington, University of Minnesota
Role in reproduction: Spermatogenesis
Project Stage: Target Validation
Alternative Name: VA w.o.w.
Active Status: Yes
User: Female
Mode: No
Delivery Type: Barrier
Developer: HLL Lifecare Limited, IXu LLC
Project Stage: SRA/WHO PQ Approved
Active Status: Unknown
User: Female
Mode: Yes
Delivery Type: Subdermal
Developer: Tehran University
Project Stage: Pre-clinical
Alternative Name: Reversible inhibition of sperm under guidance (RISUG)
Active Status: Yes
User: Male
Mode: No
Delivery Type: Vas Deferens
Developer: Indian Council for Medical Research, Indian Institute of Technology, Kharagpur
Project Stage: Phase III
Alternative Name: Ulipristal acetate (UPA) Oral
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Oral
Developer: HRA Pharma, NICHD
Project Stage: Phase II
Alternative Name: MCR-165, Medicated Contraceptive Ring-165
Active Status: Yes
User: Female
Mode: No
Delivery Type: Intrauterine
Developer: Shanghai Medical Suture Needle Factory
Project Stage: Marketed
Alternative Name: l-CDB-4022
User: Male
Mode: No
Delivery Type: Oral
Project Stage: Lead Optimization
Alternative Name: C31G Vaginal Gel
Active Status: No
User: Female
Mode: No
Delivery Type: Vaginal Gel
Developer: Adamis Pharmaceuticals
Project Stage: Phase III
Alternative Name: Depo-subQ + Uniject
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Injectable
Developer: Pfizer, PATH, USAID
Project Stage: SRA/WHO PQ Approved
Alternative Name: SCHIELD Biodegradable MPT Implant
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Subdermal
Developer: RTI International
Project Stage: Pre-clinical
Pages
